Corporate Update – Cormedix (CRMD)
Trading Performance (24‑hour period ending 04:35 PM CEST, Friday 23 Oct 2026)
- Price movement: +3.98 %
- Current price: USD 7.84
- Trading volume: USD 8.8 million
- Shares outstanding: 78.5 million
- Market capitalization: USD 607.2 million
- Year‑to‑date change (since last month‑end): +5.33 %
- 200‑day simple moving average: USD 7.68
- 52‑week range:
- High: USD 13.02 (30 Dec 2025)
- Low: USD 6.13 (6 Mar 2026)
Comparative Performance (Past 24 hours)
| Ticker | Company | Price Change | Current Price | Market Capitalization | Additional Notes |
|---|---|---|---|---|---|
| MLAB | Mesa Laboratories | –0.08 % | USD 128 | USD 723 million | P/E ratio: 152.87 |
| FUN | Six Flags Entertainment | –10.05 % | USD 7.06 | USD 723.4 million | – |
| CTKB | Cytek Biosciences | +3 % | USD 5.38 | USD 714.9 million | – |
| NNE | Nano Nuclear Energy | +2.85 % | USD 12.02 | USD 715.8 million | – |
| FDUS | Fidus Investment | +2.08 % | USD 18.38 | USD 727.4 million | P/E ratio: 8.79; filing for exemptive order with SEC (Sections 17(d) and 57(i) of the Investment Company Act, submitted 21 Oct 2026) |
Aztec Minerals Corp. – Recent Exploration Update
Aztec Minerals Corp. reported that reverse‑circulation drilling at its Tombstone property in Arizona continues to reveal oxide gold‑silver mineralization extending approximately 190 m west of the North Extension target. Nine drill holes (TR26‑45 to TR26‑53) intersected continuous and higher‑grade zones, confirming the mineralization remains open to the west, north, and at depth.
The company plans a maiden mineral resource estimate for the Tombstone project in November 2026, incorporating current results and pending assays from additional holes. Follow‑up drilling is scheduled for 2027, focusing on expanding the shallow oxide system and exploring deeper sulphide targets. These results support Aztec’s view of the Tombstone district as a highly prospective area for further gold‑silver and base‑metal discovery.
About CorMedix, Inc.
CorMedix, Inc. is a biopharmaceutical company that specializes in developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases both nationwide and internationally.
